ClinicalTrials.gg
RecruitingNCT06971497Updated Aug 28, 2026

Zimmer ActivBraid Rotator Cuff Repair (RCR) Study

An observational study in Rotator Cuff Repair of the Shoulder, sponsored by The Cleveland Clinic. Recruiting at 2 sites in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by The Cleveland Clinic · Observational

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
65
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 168 studies in Rotator Cuff Injuries with a site in United States — 40 open to participants now, 50 under way, none of them phase 3. Rotator Cuff Injuries · United States.

Planned enrollment
21st of 38
65 · median 77
Started
2025
with 10 others
Observational
38 of 168
10 open now
Primary completion
2029-08
later than 47 of 49 live
Registered
159th of 168
by date

Among the 168 studies in Rotator Cuff Injuries with a site in United States, this one is the 21st largest by planned enrollment of the 38 observational ones that give a count, is one of 11 that started in 2025, is one of 38 observational ones, reaches primary completion later than 47 of the 49 other live ones, and was the 159th registered.

Rotator Cuff Injuries

632 studies on the registry are indexed under Rotator Cuff Injuries; 157 are open to participants now.

Browse Rotator Cuff Injuries studies →

Open to participants now

40 of the 168 studies in Rotator Cuff Injuries with a site in United States are open now. Recruiting first, the newest first:

34 more — sign in →

All 40 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 100 Rotator Cuff Injuries studies recruiting now, 40 (40%) set no upper age limit and 41 (41%) stop at 75 or younger; 9 take children under 18; 10 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 168 studies in Rotator Cuff Injuries with a site in United States, or all of them as a file.
02

Study summary

We will enroll up to 65 patients undergoing primary arthroscopic rotator cuff repair (RCR) using ActivBraid™Collagen Co-Braid suture (Zimmer Biomet) and evaluate RCR healing as well as shoulder range of motion, strength, and patient-reported outcomes at 6m, 1y and 2y.

03

Conditions studied

  • Rotator Cuff Repair of the Shoulder

Browse trials for

Keywords

  • rotator cuff repair
  • shoulder
  • rotator cuff tear
  • collagen suture
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing primary arthroscopic rotator cuff repair

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-75 years
  • acute or chronic, reparable, 1-5 cm full thickness tear of the supraspinatus and/or infraspinatus tendons

Exclusion criteria

Exclusion Criteria:

  • prior ipsilateral shoulder surgery
  • outstanding worker's compensation claim
  • symptomatic cervical spine disease
  • a frozen shoulder
  • advanced glenohumeral arthritis
  • isolated subscapularis tear
  • significant radiation exposure for other medical reasons.
  • known is advance to be claustrophobic
  • known history of to bovine-derived materials.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
65 participants (estimated)
Patient registry
No

Groups and cohorts

  • patients undergoing primary arthroscopic rotator cuff repair

    Patients undergoing primary arthroscopic rotator cuff repair will have their repair completed with ActivBraid™Collagen Co-Braid suture (Zimmer Biomet).

    Device: ActivBraid™Collagen Co-Braid suture (Zimmer Biomet)

Interventions

  • DeviceActivBraid™Collagen Co-Braid suture (Zimmer Biomet)

    ActivBraid™ is a suture made from approximately half ultra-high molecular weight polyethylene and and half collagen derived from cow skin. Collagen is the most abundant protein in our bodies and serves as the building block for tendons and bones. The collagen in ActivBraid™ is intended to enhance cell attachment and tissue integration which may improve the healing of a rotator cuff repair. ActivBraid™ suture has been shown to have equivalent strength as other high strength sutures used in orthopaedic procedures and has been approved by the Food and Drug Administration (FDA) for repairing tendons. ActivBraid™ is a commercially available product that has been and is used in humans. This is the first post-market clinical study with ActivBraid™.

06

What researchers measure

Primary outcomes

  1. Rotator cuff repair healing

    Patients will undergo magnetic resonance imaging (MRI) of the shoulder from which healing of their rotator cuff repair will be classified using Sugaya score from 1-5, where higher score indicated worse healing.

    Time frame: 1 year post-operation

  2. Rotator cuff repair healing

    Patients will also undergo computed tomography (CT) scans of the shoulder from which tendon retraction of the rotator cuff repair will also be measured in millimeters where higher tendon retraction indicates worse healing.

    Time frame: 1 year post-operation

Secondary outcomes

  1. Patient-reported outcome measures

    Patients will be asked to answer the American Shoulder and Elbow Surgeons (ASES) Score from 0-100 points where higher score indicates better outcome.

    Time frame: 1 year post-operation

  2. Shoulder strength

    Isometric shoulder strength in pounds will be assessed using a table mounted dynamometer.

    Time frame: 1 year post-operation

  3. Shoulder range of motion

    Shoulder range-of-motion will be assessed by asking patients to lift their affected arm overhead in the scapular plane and measuring the range with a manual goniometer (degrees).

    Time frame: 1 year post-operation

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Aug 2029, 48 months after the start.

Of 56 non-industry observational studies under Rotator Cuff Injuries, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 67. This study's planned 48 months is above that.

Counting every sponsor, half of 71 studies reached it within 46 months; a quarter within 17 and three quarters within 165.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 29, 2025
First posted
May 14, 2025
StartActual
Aug 11, 2025
Primary completionEst.
Aug 2029
CompletionEst.
Aug 2029
Last update
Aug 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06971497
Collaborators
Zimmer Biomet
Responsible party
Kathleen Derwin, PhD (Associate Staff Scientist, The Cleveland Clinic) — Principal investigator
First posted
May 14, 2025
Start date
Aug 11, 2025
Primary completion
Aug 2029 (estimated)
Completion
Aug 2029 (estimated)
Last update
Aug 28, 2026

Study contacts

Kathleen Derwin, PhD
Contact
derwink@ccf.org
216-408-7930
Cathy Shemo, BS
Contact
shemoc@ccf.org
216-218-1722
Kathleen Derwin, PhD
principal investigator · The Cleveland Clinic
Eric Ricchetti, MD
principal investigator · The Cleveland Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion